Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To validate a mathematical algorithm that calculates risk of diabetic retinopathy progression in a diabetic population with UK staging (R0-3; M1) of diabetic retinopathy. To establish the utility of the algorithm to reduce screening frequency in this cohort, while maintaining safety standards. RESEARCH DESIGN AND METHODS: The cohort of 9690 diabetic individuals in England, followed for 2 years. The algorithms calculated individual risk for development of preproliferative retinopathy (R2), active proliferative retinopathy (R3A) and diabetic maculopathy (M1) based on clinical data. Screening intervals were determined such that the increase in risk of developing certain stages of retinopathy between screenings was the same for all patients and identical to mean risk in fixed annual screening. Receiver operating characteristic curves were drawn and area under the curve calculated to estimate the prediction capability. RESULTS: The algorithm predicts the occurrence of the given diabetic retinopathy stages with area under the curve =80% for patients with type II diabetes (CI 0.78 to 0.81). Of the cohort 64% is at less than 5% risk of progression to R2, R3A or M1 within 2 years. By applying a 2 year ceiling to the screening interval, patients with type II diabetes are screened on average every 20 months, which is a 40% reduction in frequency compared with annual screening. CONCLUSIONS: The algorithm reliably identifies patients at high risk of developing advanced stages of diabetic retinopathy, including preproliferative R2, active proliferative R3A and maculopathy M1. Majority of patients have less than 5% risk of progression between stages within a year and a small high-risk group is identified. Screening visit frequency and presumably costs in a diabetic retinopathy screening system can be reduced by 40% by using a 2 year ceiling. Individualised risk assessment with 2 year ceiling on screening intervals may be a pragmatic next step in diabetic retinopathy screening in UK, in that safety is maximised and cost reduced by about 40%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher levels of glycemia and BP, as well as the presence of nerve and renal diabetic complications, are associated with a greater likelihood of developing retinopathy.496,497”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [497]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Liew, G., Michaelides, M., & Bunce, C. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004015 · Cited by 663
Screening and prevention of diabetic blindness
Stefánsson, E., Bek, T., Porta, M., Larsen, N., Kristinsson, J. K., & Agardh, E. (2000) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.2000.078004374.x · Cited by 292
Self-citationAspelund, T., Þórisdóttir, Ó., Ólafsdottir, E., Gudmundsdottir, A., Einarsdóttir, A. B., Mehlsen, J., Einarsson, S., Pálsson, Ó., Einarsson, G., Bek, T., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2257-7 · Cited by 167
Self-citationBiennial eye screening in patients with diabetes without retinopathy: 10-year experience
Olafsdottir, E., & Stefansson, E. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.123810 · Cited by 105
Self-citationA Simple Risk Stratification for Time to Development of Sight-Threatening Diabetic Retinopathy
Stratton, I. M., Aldington, S. J., Taylor, D. J., Adler, A. I., & Scanlon, P. H. (2013) · Diabetes Care · doi:10.2337/dc12-0625 · Cited by 83
Misra, A., Bachmann, M. O., Greenwood, R. H., Jenkins, C., Shaw, A., Barakat, O., Flatman, M., & Jones, C. D. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02820.x · Cited by 72
Validation of a model to estimate personalised screening frequency to monitor diabetic retinopathy
van der Heijden, A. A. W. A., Walraven, I., Riet, E. V. ‘., Aspelund, T., Lund, S. H., Elders, P. J. M., Polak, B. C. P., Moll, A. C., KEUNEN, J. E. E., Dekker, J. M., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3246-4 · Cited by 44
Self-citationScreening for diabetic retinopathy: Initiation and frequency
Kristinsson, J. K., Guðmundsson, J. R., Stefánsson, E., Jónasson, F., Gíslason, I., & Þórsson, Á. V. (1995) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.1995.tb00329.x · Cited by 43
Self-citationSoto‐Pedre, E., Piniés, J. A., & Hernáez-Ortega, M. C. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.12.020 · Cited by 28
Cited by
Screening for diabetic retinopathy: new perspectives and challenges
Vujosevic, S., Aldington, S. J., Silva, P., Hernández, C., Scanlon, P., Peto, T., & Simó, R. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30411-5 · Cited by 671
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
The English National Screening Programme for diabetic retinopathy 2003–2016
Scanlon, P. H. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0974-1 · Cited by 440
A deep learning system for predicting time to progression of diabetic retinopathy
Dai, L., Sheng, B., Chen, T., Wu, Q., Liu, R., Cai, C., Wu, L., Yang, D., Hamzah, H., Liu, Y., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02702-z · Cited by 339
Interventions to increase attendance for diabetic retinopathy screening
Lawrenson, J. G., Graham-Rowe, E., Lorencatto, F., Burr, J., Bunce, C., Francis, J. J., Aluko, P., Rice, S., Vale, L., Peto, T., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012054.pub2 · Cited by 92
Metadata
- Authors
- Lund, S. H., Aspelund, T., Kirby, P., Russell, G., Einarsson, S., Palsson, O., & Stefánsson, E.
- Affiliations
- University of Iceland (IS)
- Corresponding author
- Stefánsson, E
- Venue
- British Journal of Ophthalmology
- Publisher
- BMJ
- Published
- 2015-09-16
- Volume
- 100
- Issue
- 5
- Pages
- 683-687
- ISSN
- 0007-1161 (ISSN-L)
- 1468-2079
- PMC
- PMC4853547
- OpenAlex
- W2264654258
- Cited by
- 84
- References
- 12
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 11 · 2023: 10 · 2022: 13 · 2021: 9 · 2020: 13 · 2019: 5 · 2018: 4 · 2017: 6 · 2016: 4
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- British Journal of Ophthalmology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetic retinopathy, risk prediction algorithm, type 2 diabetes, proliferative diabetic retinopathy, diabetic maculopathy, retinopathy progression, healthcare cost reduction, screening safety
- MeSH terms
- Algorithms, Diabetes Mellitus, Type 2, Diabetic Retinopathy, England, False Positive Reactions, Female, Humans, Male, Mass Screening, Mathematics, Predictive Value of Tests, ROC Curve, Time Factors, Health Care Costs, Disease Progression, Risk Assessment, Area Under Curve
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs. https://app.cochat.ai/papers/10.1136/bjophthalmol-2015-307341
- The paper
- Lund, S. H., Aspelund, T., Kirby, P., Russell, G., Einarsson, S., Palsson, O., & Stefánsson, E. (2016). Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs. British Journal of Ophthalmology. https://doi.org/10.1136/bjophthalmol-2015-307341
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.